LIPIDS: 60 Second Insights
Published: 10 August 2018
-
Views:
892
-
Likes:
7
-
Views:
892
-
Likes:
7
-
Up Next -
53sPart 8 | Session 2 Wolfgang Koenig
-
44sPart 1 | Session 1 Christopher Cannon Christopher P Cannon
-
50sPart 1 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
46sPart 2 | Session 1 Christopher Cannon Christopher P Cannon
-
34sPart 2 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
38sPart 3 | Session 1 Christopher Cannon Christopher P Cannon
-
1m 25sPart 3 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
45sPart 4 | Session 1 Christopher Cannon Christopher P Cannon
-
53sPart 4 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
31sPart 5 | Session 1 Christopher Cannon Christopher P Cannon
-
48sPart 5 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
47sPart 6 | Session 1 Christopher Cannon Christopher P Cannon
-
53sPart 6 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
43sPart 7 | Session 1 Christopher Cannon Christopher P Cannon
-
57sPart 7 | Session 2 Wolfgang Koenig Wolfgang Koenig
Overview
A short series of 60-second insight videos on the LIPIDS trial.
More from this programme
Part 1
Which emerging compounds show the most promise in reducing LDL?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 2
What is required for PCSK9s to get wider spread adoption?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 3
How important is inflammation in atherosclerosis?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 4
Are statins over (or under) prescribed?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 5
Is cholesterol being managed sub- optimally? If so, what needs to improve?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 6
How low should LDL go?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 7
Is HDL good cholesterol?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 8
What is the greatest unmet need in lipid management?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Faculty Biographies
Christopher P Cannon
Professor
Dr Christopher Cannon is a Professor of Medicine at Harvard Medical School, and Senior Physician in the Preventive Cardiology section of the Cardiovascular Division at Brigham and Women’s Hospital.
He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center, and cardiovascular fellowship at Brigham and Women’s Hospital.
Dr Cannon has published over 1000 original articles, reviews or book chapters in the field of acute coronary syndromes and prevention and has authored or edited 18 books. He has received numerous awards, including leadership awards from the American College of Cardiology, American Heart Association and National Lipid Association.
He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18, PROVE IT, IMPROVE IT, RE-DUAL PCI and VERTIS CV trials.
Dr Cannon is on the…